BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33039851)

  • 1. Genetic alterations in non-syndromic, familial gliomas in first degree relatives: A systematic review.
    Vasilica AM; Sefcikova V; Samandouras G
    Clin Neurol Neurosurg; 2020 Nov; 198():106222. PubMed ID: 33039851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of p53 tumor suppressor gene in families with multiple glioma patients.
    Paunu N; Syrjäkoski K; Sankila R; Simola KO; Helén P; Niemelä M; Matikainen M; Isola J; Haapasalo H
    J Neurooncol; 2001 Dec; 55(3):159-65. PubMed ID: 11859970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor genomic profiling and TP53 germline mutation analysis of first-degree relative familial gliomas.
    Idbaih A; Boisselier B; Sanson M; Crinière E; Liva S; Marie Y; Carpentier C; Paris S; Laigle-Donadey F; Mokhtari K; Kujas M; Hoang-Xuan K; Delattre O; Delattre JY
    Cancer Genet Cytogenet; 2007 Jul; 176(2):121-6. PubMed ID: 17656254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.
    Wakimoto H; Tanaka S; Curry WT; Loebel F; Zhao D; Tateishi K; Chen J; Klofas LK; Lelic N; Kim JC; Dias-Santagata D; Ellisen LW; Borger DR; Fendt SM; Vander Heiden MG; Batchelor TT; Iafrate AJ; Cahill DP; Chi AS
    Clin Cancer Res; 2014 Jun; 20(11):2898-909. PubMed ID: 24714777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the H3K27M mutation on survival in pediatric high-grade glioma: a systematic review and meta-analysis.
    Lu VM; Alvi MA; McDonald KL; Daniels DJ
    J Neurosurg Pediatr; 2018 Nov; 23(3):308-316. PubMed ID: 30544362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Classification of Diffuse Gliomas.
    Kalidindi N; Or R; Babak S; Mason W
    Can J Neurol Sci; 2020 Jul; 47(4):464-473. PubMed ID: 31918786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Description of selected characteristics of familial glioma patients - results from the Gliogene Consortium.
    Sadetzki S; Bruchim R; Oberman B; Armstrong GN; Lau CC; Claus EB; Barnholtz-Sloan JS; Il'yasova D; Schildkraut J; Johansen C; Houlston RS; Shete S; Amos CI; Bernstein JL; Olson SH; Jenkins RB; Lachance D; Vick NA; Merrell R; Wrensch M; Davis FG; McCarthy BJ; Lai R; Melin BS; Bondy ML;
    Eur J Cancer; 2013 Apr; 49(6):1335-45. PubMed ID: 23290425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
    Chen R; Cohen AL; Colman H
    Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and Correlation of Single and Concomitant
    Pessôa IA; Amorim CK; Ferreira WAS; Sagica F; Brito JR; Othman M; Meyer B; Liehr T; de Oliveira EHC
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31151164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite instability, PTEN and p53 germline mutations in glioma families.
    Malmer B; Grönberg H; Andersson U; Jonsson BA; Henriksson R
    Acta Oncol; 2001; 40(5):633-7. PubMed ID: 11669337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis.
    Laffaire J; Everhard S; Idbaih A; Crinière E; Marie Y; de Reyniès A; Schiappa R; Mokhtari K; Hoang-Xuan K; Sanson M; Delattre JY; Thillet J; Ducray F
    Neuro Oncol; 2011 Jan; 13(1):84-98. PubMed ID: 20926426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnostics of gliomas.
    Nikiforova MN; Hamilton RL
    Arch Pathol Lab Med; 2011 May; 135(5):558-68. PubMed ID: 21526954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Review of Molecular Targeted Therapies for Adult-Type Diffuse Glioma: An Analysis of Clinical and Laboratory Studies.
    Muzyka L; Goff NK; Choudhary N; Koltz MT
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
    Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
    Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline mutations in shelterin complex genes are associated with familial glioma.
    Bainbridge MN; Armstrong GN; Gramatges MM; Bertuch AA; Jhangiani SN; Doddapaneni H; Lewis L; Tombrello J; Tsavachidis S; Liu Y; Jalali A; Plon SE; Lau CC; Parsons DW; Claus EB; Barnholtz-Sloan J; Il'yasova D; Schildkraut J; Ali-Osman F; Sadetzki S; Johansen C; Houlston RS; Jenkins RB; Lachance D; Olson SH; Bernstein JL; Merrell RT; Wrensch MR; Walsh KM; Davis FG; Lai R; Shete S; Aldape K; Amos CI; Thompson PA; Muzny DM; Gibbs RA; Melin BS; Bondy ML;
    J Natl Cancer Inst; 2015 Jan; 107(1):384. PubMed ID: 25482530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant glioma].
    Okamura K
    Nihon Rinsho; 1995 Nov; 53(11):2678-83. PubMed ID: 8538025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.
    Akyerli CB; Yüksel Ş; Can Ö; Erson-Omay EZ; Oktay Y; Coşgun E; Ülgen E; Erdemgil Y; Sav A; von Deimling A; Günel M; Yakıcıer MC; Pamir MN; Özduman K
    J Neurosurg; 2018 Apr; 128(4):1102-1114. PubMed ID: 28621624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Factors and Resectability Predictors in Insular Gliomas: A Systematic Review.
    Papadopoulou A; Kumar NS
    J Neurol Surg A Cent Eur Neurosurg; 2024 Jan; 85(1):74-87. PubMed ID: 37619597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.